Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Suvankar Banerjee, Shristi Kejriwal, Balaram Ghosh, Goverdhan Lanka, Tarun Jha & Nilanjan Adhikari. (2023) Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors: a cross-validated approach of ligand-based and structure-based molecular modeling studies. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-17.
Read now
Read now
Articles from other publishers (11)
Tiantian Wu, Changsheng Pu, Qiang Wang & Keming Zhang. (2023) Comparison of Efficacy and Safety of Anti-Programmed Cell Death-1 Antibody Plus Lenvatinib and Chemotherapy as First-Line Therapy for Patients with Stage IV Gallbladder Cancer: A Real-World Study in a Chinese Population. Biomedicines 11:11, pages 2933.
Crossref
Crossref
Duván A. Rodríguez Enciso, Carlos E. Puerto Galvis & Vladimir V. Kouznetsov. (2023) Microwave-assisted Synthesis of Pharmacologically Active 4-Phenoxyquinolines
and their Benzazole-quinoline Hybrids Through SNAr Reaction of
4,7-dichloroquinoline and Phenols Using [bmim][PF6] as a Green Solvent. Current Organic Synthesis 20:5, pages 546-559.
Crossref
Crossref
Parteek Prasher, Mousmee Sharma, Yinghan Chan, Sachin Kumar Singh, Krishnan Anand, Harish Dureja, Niraj Kumar Jha, Gaurav Gupta, Flavia Zacconi, Dinesh K. Chellappan & Kamal Dua. (2023) Recent Trends in Rationally Designed Molecules as Kinase Inhibitors. Current Medicinal Chemistry 30:13, pages 1529-1567.
Crossref
Crossref
Lantian Wang, Kezhong Tang, Xiawei Li & Wenjie Lu. (2022) Anti-PD-1-based immunotherapy plus lenvatinib to treat advanced gallbladder cancer in the elderly: a case series and review of current literature. Journal of Cancer Research and Clinical Oncology 149:3, pages 941-950.
Crossref
Crossref
Flávia Melo Cunha de Pinho Pessoa, Caio Bezerra Machado, Emerson Lucena da Silva, Laudreísa da Costa Pantoja, Rodrigo Monteiro Ribeiro, Maria Elisabete Amaral de Moraes, Manoel Odorico de Moraes Filho, Raquel Carvalho Montenegro, André Salim Khayat & Caroline Aquino Moreira-Nunes. (2022) Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution. International Journal of Molecular Sciences 23:7, pages 3830.
Crossref
Crossref
Minghuang Hong, Shijia Li, Weijie Ji, Ming-Hui Qi & Guo-bin Ren. (2021) Cocrystals of Lenvatinib with Sulfamerazine and Salicylic Acid: Crystal Structure, Equilibrium Solubility, Stability Study, and Anti-Hepatoma Activity. Crystal Growth & Design 21:7, pages 3714-3727.
Crossref
Crossref
Martina Spisarová, Bohuslav Melichar, Denisa Vitásková & Hana Študentová. (2021) Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma. Future Oncology 17:3, pages 241-254.
Crossref
Crossref
Faheem Shaik, Gary Cuthbert, Shervanthi Homer-Vanniasinkam, Stephen Muench, Sreenivasan Ponnambalam & Michael Harrison. (2020) Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy. Biomolecules 10:12, pages 1673.
Crossref
Crossref
Jin Hong Lim, Kyung Hwa Choi, Soo Young Kim, Cheong Soo Park, Seok-Mo Kim & Ki Cheong Park. (2020) Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis. International Journal of Molecular Sciences 21:20, pages 7469.
Crossref
Crossref
Boris Itkin, Alastair Breen, Lyudmila Turyanska, Eduardo Omar Sandes, Tracey D. Bradshaw & Andrea Irene Loaiza-Perez. (2020) New Treatments in Renal Cancer: The AhR Ligands. International Journal of Molecular Sciences 21:10, pages 3551.
Crossref
Crossref
Jing Xie, Hang Huang, Tong Xu, Renhao Li, Jiuxi Chen & Xueting Ye. (2020)
The synthesis of quinolines
via
denitrogenative palladium-catalyzed cascade reaction of
o
-aminocinnamonitriles with arylhydrazines
. RSC Advances 10:15, pages 8586-8593.
Crossref
Crossref